VYNE Therapeutics Inc.
VYNE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,834 | -$28,452 | -$23,210 | -$73,329 |
| Dep. & Amort. | $4 | $0 | $72 | $109 |
| Deferred Tax | $0 | $0 | $0 | $1,525 |
| Stock-Based Comp. | $3,303 | $3,305 | $4,297 | $8,080 |
| Change in WC | $4,999 | $60 | $2,277 | $4,776 |
| Other Non-Cash | -$2,444 | -$254 | -$12,636 | $2,472 |
| Operating Cash Flow | -$33,972 | -$25,341 | -$29,200 | -$56,367 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$117 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $5,000 | $15,667 | $0 |
| Inv. Purchases | -$60,518 | -$62,354 | $0 | $0 |
| Inv. Sales/Matur. | $84,000 | $0 | $0 | $1,027 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $23,365 | -$57,354 | $15,667 | $1,027 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$36,432 |
| Stock Issued | $0 | $82,821 | $1,470 | $75,981 |
| Stock Repurch. | -$141 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$427 | $183 | $228 |
| Financing Cash Flow | -$141 | $82,394 | $1,653 | $39,777 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,748 | -$301 | -$11,880 | -$15,563 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,674 | $30,975 | $42,855 | $58,418 |
| End Cash | $19,926 | $30,674 | $30,975 | $42,855 |
| Free Cash Flow | -$34,089 | -$25,341 | -$29,200 | -$56,367 |